Skip to content

Study · Case report or series · n = 1 · 2012

1 result

[Dermoscopic changes in melanocytic nevi during use of melanotan II].

Mang R, Krahl D, Assmann T

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete1 Nov 2012Cited by 4 (Europe PMC)

PMID23052015 (opens in a new tab)DOI10.1007/s00105-012-2420-1 (opens in a new tab)PepBankPUB-23052015
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesSafety outcome

    In a 24-year-old man using subcutaneous melanotan II, dermoscopic changes in nevi made it difficult to tell a nevus from a melanoma.

    In plain wordsIn one man who injected melanotan II, moles changed in a way that made them hard to tell apart from skin cancer.

    Peptide
    Melanotan II
    Outcome
    Not applicableDermoscopic changes in melanocytic nevi
    Study

    n = 1

    Outcome group
    Skin and hair · Skin and wound
    Studied dose
    Dose not stated · subcutaneousAs given in this study (human).

    Source sentences

    Summary
    The observed dermoscopic changes made it difficult to differentiate a nevus from a melanoma.
    2 context sentences
    Summary · context
    For cosmetic reasons, a 24-year-old man performed subcutaneous autoinjections with a preparation having alpha-MSH-like effects (melanotan II) purchased via the internet.
    Summary · context
    The changes of patient's nevi were documented by sequential videodermoscopy before and during treatment.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 17:28 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.